- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
10
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
10 companies
Abbott India
Market Cap: ₹658.2b
Operates as a pharmaceutical company in India.
500488
₹30,975.50
7D
-3.8%
1Y
4.3%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹485.1b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,863.80
7D
0.8%
1Y
0.06%
Blue Jet Healthcare
Market Cap: ₹118.5b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹682.85
7D
-3.6%
1Y
34.5%
Sanofi India
Market Cap: ₹117.1b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹5,082.60
7D
-0.5%
1Y
-29.6%
Jeena Sikho Lifecare
Market Cap: ₹94.1b
Trades in ayurvedic medicines in India.
JSLL
₹756.85
7D
-2.9%
1Y
168.9%
RPG Life Sciences
Market Cap: ₹39.5b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,389.20
7D
0.6%
1Y
3.9%
Influx Healthtech
Market Cap: ₹4.4b
Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.
INFLUX
₹189.55
7D
-1.9%
1Y
n/a
Asston Pharmaceuticals
Market Cap: ₹893.9m
Engages in the manufacturing and selling of pharmaceutical formulations and nutraceutical products in India, West Africa, South Africa, and rest of Asia.
544445
₹105.00
7D
2.4%
1Y
n/a
Accretion Pharmaceuticals
Market Cap: ₹705.9m
Manufactures and sells pharmaceutical products in India.
ACCPL
₹63.50
7D
0.8%
1Y
n/a
Genesis IBRC India
Market Cap: ₹630.9m
Does not have significant operations.
514336
₹48.53
7D
27.6%
1Y
221.4%